Supernus Pharmaceuticals (S49.F) Q3 2025 Earnings

Aug 5Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
0.33
0.58
0.83
1.07

Details

Expected EPS
0.4059719
Actual EPS
0.78468840142
Surprise EPS
0.38
Surprise Percent
+93.29%

Description

⁨Supernus Pharmaceuticals⁩ (⁦S49.F⁩) has reported earnings of ⁦0.78468840142⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts